Prerpints.org logo
Preprint
Review

Quantitative Structure-Activity Relationship of Alkaloids with Immunomodulatory Effects

Altmetrics

Downloads

108

Views

50

Comments

0

Submitted:

05 June 2024

Posted:

07 June 2024

You are already at the latest version

Alerts
Abstract
Natural products are considered an essential source of chemical compounds with relevant biological activities. Important antibiotics, anti-virals, and anticancer agents within healthcare facilities have been isolated from them. In recent decades, the study of alkaloids and the modulation of the immune response has aroused interest. The survey of SAR alkaloids with immunomodulatory effects is of great importance since structural modifications impact the effectiveness of the immunomodulatory activity, thus promoting the rational design of more effective and specific drugs. This review exhibits the main alkaloids with an immunomodulatory effect and their relationship with SAR studies, particularly in activating leukocytes and secretion of molecules with critical inflammatory activities such as cytokines, chemokines, and nitric oxide. These studies optimize the properties of alkaloids and allow a deeper understanding of the mechanisms of action at a molecular level, which is fundamental for the innovation of immunological therapies.
Keywords: 
Subject: Biology and Life Sciences  -   Biology and Biotechnology

1. Introduction

All living cells produce metabolites due to their biochemical process during metabolism; one of the most studied is phytochemicals, considered primary and secondary metabolites and exhibit a comprehensive chemical composition and structural features [1]. Regarding plant physiology, secondary metabolites are involved in several mechanisms such as defense, signaling, and regulation [2,3]. Additionally, they are related to enhancing diverse cellular pathways such as cell activation and proliferation [4,5]. Their constant existence in nature results in a highly attractive chemical compound as a source of new drugs [6].
Therefore, natural products, including plants, animals, and fungi, have been a source of natural treatment for diverse diseases. They represent an essential fraction of drugs used in health facilities. They are characterized by their enormous and complex structural and physicochemical diversity, including rigid or semi-rigid cyclic features, proton donors and acceptors, and chiral centers [6,7]. For this reason, natural products can be categorized into phenolic compounds, polyketides, terpenoids, and alkaloids [8,9].
About 40,000 alkaloids are known and present structural features involving heterocyclic rings and a nitrogen atom and they are currently of great pharmacological importance. Since a significant source of alkaloid skeleton is derived from amino acid metabolism, they could be classified according to their precursors based on the biological pathway used to build the molecule [10,11]. Therefore, could be categorized into three large groups: true alkaloids, protoalkaloids (both derived from amino acids) and pseudoalkaloids (not derived from amino acids) [12,13,14,15]. They present a broad spectrum of biological activities such as anti-microbial [16,17,18], anti-viral [18,19], anti-diabetic [20], anti-carcinogenic [8,9,18,21,22,23], antioxidant [24], anti-parasitic [25]. Additionally, they are widely related to improving diverse biochemical factors during nervous, cardiovascular, and chronic degenerative diseases, such as diabetes and high blood pressure [26,27,28]. Alkaloids from the indole family contain chemotherapeutic drugs, such as Vinblastine, that present structural features intervening with cellular mechanisms by inhibiting the formation of spindle fibers, responsible for chromosome alignment and separation in anaphase promoting a decrease of cancer cells during mitosis [26,29,30,31,32].
Cyclic structures, such as chalcone [33], isoflavone [34] coumarin [35], are present in several alkaloid groups with pharmacological properties (Figure 1). For example, the quinoline ring, isoquinoline [36], indole [37], and pyrrolidine [38], function as chemical skeletons that are used for the development of new drugs [20] (Figure 1). For this reason, the knowledge of the chemical structure of a natural product and its biological activities has gained importance regarding new drug design in the last decade [39].
Although diverse alkaloids have shown biological activities, generating new chemical entities with less toxicity, side effects, and selective activity can develop by studying the structure-activity relationship (SAR) [4,40]. The intermolecular interactions between an alkaloid and a biologically important molecule, such as a hormone receptor, DNA, or ribosome, can be accomplished if the target structure is known, and computational chemistry and molecular modeling software packages can be useful in identifying binding site interactions [40].
SAR is often observed through computational chemistry and modeling software (if the chemical compound is known) and non-computational methods if the chemical compound is not known, such as synthesis of structure variants adding or removing functional groups. For in silico studies, parameters such as the number of rotary bonds, chiral centers, a fraction of Csp3 atoms, cyclic motifs, aromatic rings, nitrogen and oxygen atoms, number of hydrogen acceptors and donors, the number of acidic and basic atoms are considered [4,40]. Physicochemical properties are also included due to their essential role in the selective activity of natural compounds, such as solubility in organic or inorganic solvents. Interestingly, in an in vivo scenario, they may determine the absorption, distribution, and drug metabolism [22].
Currently, computer tools help predict and investigate the biological activities of compounds according to specific molecular characteristics. Using in silico analysis facilitates the modification of molecules or the design of new drugs, giving quantitative results for each molecule and particular activity according to descriptors based on geometric, topological, physical-chemical, and constitutional algorithms. As it is associated with subsequent in vitro studies, the efficacy of these new entities can be evaluated [41,42]. Diverse approaches in drug design have been used, such as structure-based, ligand-based drug design, and virtual detection. They are based on a target macromolecule or receptor that interacts with a drug, accelerating the entire process of discovery of chemical entities [43]. Structure-based drug design is performed with available structural models of the target molecule, which are obtained by X-ray diffraction [44], nuclear magnetic resonance (NMR) [45], or molecular simulation [46]. Once this information is obtained, the software analyzes the physicochemical properties of the receptor's drug-binding sites, followed by searching for existing molecules compatible with the receptor or the design of a new drug [43]. Ligand-based drug design is established by collecting known molecules that bind to the target macromolecule of interest [47], instead of structure-based drug design, which considers the receptor structure. The minimum necessary structural characteristics that a molecule must possess to bind to the target are defined using these known molecules. Likewise, this information can be used to build a model with Quantitative structure-activity relationship (QSAR) and predict the molecule's activity [43]. Virtual detection is essential for computer-aided drug design since identifying potential drugs is faster and cheaper than conducting trial-and-error experimental studies [48]. To date, there are many known alkaloids with immunomodulatory effects; however, more studies need to be conducted that include SAR analysis.
The modulation of the immune system by natural products, such as alkaloids or synthetic products, has gained importance in recent years due to its fundamental importance during new drug development [40,41,42,43,44,45]. Alkaloids are essential in immunomodulating intracellular signaling pathways involving inflammation responses by inducing inflammatory cytokines, cell proliferation, cell cycle arrest, T-cell activation, leukocyte recruitment, and adhesion molecule expression. These are through activating signaling pathways such as MAPK and JAK/STAT, which trigger inflammation transcription factors NFkB and AP-1 [6]. During an immune response, the role of these mediators impacts the recruitment of leukocytes, mainly neutrophil cells, in the infection site to eliminate foreign agents and then promote effector T or B cell homeostasis, leading to an inflammatory response regulation [7,49]. Thus, cancer-linked inflammation is essential in cancer development [6]. Chronic inflammation leads to loss of tissue structure and remodeling and oxidative stress by protein and DNA modification, increasing cancer risk development [50,51]. Additionally, during cancer development, inflammatory molecules such as reactive oxygen species, cytokines and chemokines, among others, may be derived from tumor-immune infiltrated cells. This review summarizes studies of QSAR of several alkaloids and their derivates regarding immunomodulatory activity, exposing the importance of developing more effective drugs with fewer side effects.
Chemical Modification
Synthetic and semi-synthetic compounds that explore biological activities in a dependent and rational manner are essential for drug discovery. To fully understand the immunological implication of alkaloids and their derivates on the host immune system, chemical modification has been made to study activity-structure relationships, aiming to improve the pharmacological properties based on activity-structure relationship analyses [31]. These modifications are established on drug modulation and structure-activity relationship analysis principles using different methods such as conventional reactions, combinatorial chemistry, and biotransformation [7].
The most frequent addition of functional groups that are found in drugs nowadays employed are hydrocarbon structures such as methoxy (OCH3), ethoxy (OCH2CH) isopropoxy [OCH (CH3)2], or methylenedioxy (OCH2O) groups, as well as other functional groups such as esters (RCOOR'), amides (NH2, NHR or NRR), sulfonates (R-SO3-), aminomethyl (MeN), sulfonamides (-SO2N<), hydroxyls (OH) or halogens (Br, Cl). Therefore, the structural modification of compounds, in many cases, potentiates their biological activities with capacities even superior to the native natural product from which they come naturally [7].
Alkaloids with immunomodulatory effects and QSAR evaluation
Since alkaloids are molecules of high pharmacological interest, they have been studied for their wide range of biological activities, as previously described. Therefore, the characterization of their chemical structures and their synthetic derivates is an attractive study subject for designing new immune response modulation drugs (Table 1).
True Alkaloids
True alkaloids are structurally complexes that derive from cyclic amino acids and are characterized by intracyclic nitrogen. They derived from amino acids such as L-ornithine, L-tyrosine, L-phenylalanine, L-lysine, L-histidine, L-tryptophan, L-arginine, and glycine/aspartic acid [11,13,14,52].
Aspartate-derived alkaloids are valuable compounds for pharmaceutical research and drug development due to their diverse biological activities (Table 1). A representative member of this family with QSAR and immunomodulatory effect is the indanone scaffold. This molecule is considered a privileged structure in medicinal chemistry. Indanone and its hydroxylated derivatives are well-documented for their diverse biological activities, such as anti-inflammatory and anti-cancer properties [53,54]. During inflammatory bowel disease (IBD) in vitro and in vivo [53], pyridine-linked indanone derivates were used to evaluate the inflammatory response by measuring cytokine tumor necrosis factor-α (TNF-α), a pro-inflammatory cytokine strongly related during IBD by enhancing inflammation through leukocyte recruitment to the infected site. Interestingly, pyridine-linked indanone derivates with methoxy, ethoxy, or isopropoxy groups induced a strong activity inhibiting TNF-α in monocyte adhesion by HT-29 colon epithelial cells. Additionally, in an induced rat colitis model, this derivates enriched colitis by altering the expression of inflammatory cytokines such as IL-1β, TNF-α, and the calcium-dependent cell-cell adhesion molecule, E-cadherin with pivotal roles in epithelial cell behavior, tissue formation, and suppression of cancer [53]. These results suggest that these compounds can reverse the damage and dysfunction caused by chronic inflammation, highlighting their therapeutic potential in clinical contexts. Suggesting that pyridine-linked indanone derivates can interfere with critical inflammatory pathways, making them promising candidates for new treatment development for IBD and other inflammatory diseases. Understanding how these compounds modulate the immune response at the molecular and cellular levels can provide valuable insights into specific mechanisms of action. This is crucial for optimizing drug design, improving efficacy, and minimizing side effects.
Several phenylalanine and tyrosine-derived alkaloids exhibited a broad significative pharmacological activity, such as the analgesics morphine and codeine, as the immunomodulatory Berberine, the latter being an essential representative family member of the Isoquinoline alkaloids. Berberine is one of the most studied alkaloids of this family for its anti-proliferative [51,55], antimicrobial [16,18], anti-diabetic [56] and anti-inflammatory properties [51,57], making it a molecule of great biological interest. Berberine derivatives with substituents with esterification (C3) and the addition of esters, amides, and sulfonates at position C9 down-regulated IFN-γ-induced promoter activity on the enzyme indoleamine 2,3-dioxygenase (IDO1) in A-549 human cancer cell line [58]. SAR studies indicated that large volume substituent at the 9-position is beneficial for enhancing the suppression of IFN-g-induced IDO1 promoter. INF-γ is a cytokine that is produced by activated T and NK cells and plays a crucial role in regulating various immune responses, as macrophage activation and enhancement of antigen presentation and therefore in the context of chronic inflammatory diseases, such as autoimmune, is often involved in the pathogenesis as tissue damage. Additionally, to elucidate the possible mechanism of action of the derivatives, their immunosuppressive effect was evaluated by acting on IDO1 by western blot. Several berberine derivates suppressed IFN-γ-induced IDO1 expression by activating AMPK by inhibiting STAT1 phosphorylation, demonstrating its relevance as a potential cancer immunotherapy drug [58].
Protoalkaloids
The principal structural feature of protoalkaloids is that they present a nitrogen atom but are not part of the heterocyclic ring and they may be derived from amino acids as L-tyrosine and L-tryptophan or amines [8,13,15,52]. Several indol alkaloids exhibited a broad biological activity, such as anti-microbial, antiproliferative, and anti-inflammatory, making this compound of interest in medicine and the pharmaceutical industry. One of the most studied regarding immunomodulation with SAR is phidianidines A and B. Isolated from marine sources presents diverse biological activities such as cytotoxic, neuroprotective, dopamine transporter inhibitory, and protein tyrosine phosphatase-1B inhibitory activities. Thirty-two phidianidines derivates were synthesized and the immunosuppressive activity of murine splenocytes was analyzed by measuring murine T and B-cell proliferation and analyzed by SAR [59]. Two derivates exhibited that the 1,2,4-oxadiazole ring and the 3,4,5 trimethoxyphenyl ring substitution played an essential role in the activity since they showed a highly inhibitory activity on T and B cell proliferation. In other studies, stimulated anti-CD3/CD28 antibody T-cells mimic the physiologic cross-linking of TCR. The results show that both derivatives suppress the proliferation of CD4+ T-cells, the secretion of IL-2 and IFN-γ, and the presence of CD25. For B-cell function, the derivates strikingly inhibited CD19+ B lymphocytes and showed regulatory effects on cytokine production, decreasing IL-6 and increasing IL-10 secretion. Phidianidine derivatives exhibited a potent immunosuppressive effect in vitro, including T and B-cell proliferation, activation and cytokine production. These chemical additions are essential for the immunomodulatory effect of these alkaloids, and due to their immunosuppressive effects and low toxicity, they are candidates for future in vivo research in immunological diseases [59].
Another important tryptophan-derived alkaloid is heterotetracyclic ellipticine, which presents diverse biological activities and immunomodulatory effects. Ellipticine derivates were synthesized [sodium bromo-5,11-dimethyl-6H-pyrido[4,3-b] carbazole-7-sulfonate (Br-Ell-SO3Na)] and studied SAR regarding immunomodulation [60]. The cytotoxicity of Br-Ell-SO3Na was tested in K562, Vero cell line and PBMC, the immunomodulatory activity was analyzed by measuring diverse interleukins. Ellipticine derivate Br-Ell-SO3Na showed the up-regulation of IL-6. This cytokine is related to various inflammatory and autoimmune diseases and, during acute inflammation, induces leukocyte recruitment, mainly neutrophils, to the infection site by regulating adhesion molecules and chemotaxis and stimulating the differentiation of T and B-cells, among others. Additionally, Br-Ell-SO3Na inhibited the expression of IL-8, a chemokine that, during cancer development, is associated with metastasis, angiogenic response, proliferation, survival, and migration of vascular endothelial cells. Both are pro-inflammatory biomarkers and are usually stimulated together during disease [60].
By QSAR and Docking, ellipticine derivates have been analyzed on three different proteins with high significance during leukemia as SYK (spleen tyrosine kinase), PI3K (phosphoinositide 3-kinase), and BTK (Bruton's tyrosine kinase), selected by their relevance during preclinical models. Derivates showed a high activity binding regarding their molecular structure, and several modifications were made to enhance their biological activity. Mainly, ellipticine derivatives with a hydrophobic substituent like a benzene ring increased the antileukemia activity (compound 9), and an aromatic ring bound to the ester moiety enhanced the biological activity (compound 22) [61].
Another member of the Indole alkaloids is β-carboline. By 3D-QSAR, several derivates were designed [62] and evaluated regarding the immunomodulatory effect in macrophages RAW 264.7, and the relationship between the chemical structure and anti-inflammatory impact was shown in several derivates by inhibiting nitric oxide (NO) production. NO is crucial for the proper functioning of macrophages. It enhances their ability to combat pathogens, regulates inflammation, influences macrophage activation and migration, promotes tissue repair, and plays a role in apoptosis and cytotoxicity. The balanced production and regulation of NO are essential for effective immune responses and maintaining tissue homeostasis. Thus, β-carboline alkaloid derivates present an attractive potential pharmacological agent with immunosuppressive potential [62].
Pseudoalkaloids
This group of alkaloids is not necessarily derived from amino acids; several pseudoalkaloids have nonamino acid precursors, and others are derived from transamination or amination reactions [15,52]. Diterpenoid alkaloids have been studied regarding their anti-inflammatory activity using QSAR to obtain molecular structure parameters and establish a predictive model for measuring the maximum mean effective concentration (EC50) [63]. With QSAR analysis, three diterpenoids songorine, delsolin, and fulzulin were studied, with EC50 of 0.301, 4.0517, and 3.8805 respectively, a lower value of EC50 indicating a more significant activity of the compound. Microglial cells (N9) were stimulated with LPS to analyze the anti-inflammatory effect and evaluate the NO release. Songorin inhibited NO production in LPS-activated N9 cells, dose-dependent, without apparent cytotoxicity, suggesting that it could be a potential inflammatory inhibitor, according to the model prediction (Log (EC50) = 0.301). However, fuzilin and delsolin did not exhibit inhibitory effects at the concentrations tested, according to the predicted value of the model [63]. QSAR is one of the models to help predict biological activities for new drug candidates.
Several natural products, semi-synthetic or synthetic entities exhibited a broad spectrum of biological activities. These are attributed to the chemical structure, presenting relevance during new drug design with less toxicity, side effects, and selective activity. In this review, we concentrated on studies that evaluated alkaloids with immunomodulatory effects and made a SAR analysis. The SAR analysis is of great interest; developing new molecular molecules to synthesize drugs with greater selectivity and less toxicity is necessary.

2. Conclusion

The study of the SAR of alkaloids and their derivates related to immunomodulatory effect is crucial for promoting innovation in biomedical and pharmaceutical science, leading to the discovery of new therapeutic molecules and the creation of advanced technological platforms for drug design. Understanding how the chemical structure of alkaloids influences their biological activity, as well as the identification, selection, and optimization, will improve the immunomodulatory efficacy, leading to safer and more effective drugs. These studies will improve the understanding of the biology of the immune system and expose new opportunities for potential therapeutic intervention in diseases involving inflammatory diseases.

Author Contributions

A.A.C.E. and J.T.D.J.Q.V. contributed to the data analysis and drafted the paper. J.C.G.R., J.D.C. and D.E.V.R. contributed to the critical reading of the manuscript. All the authors have read the final manuscript and approved the submission.

Funding

This review was funded by the Facultad Interdisciplinaria de Ciencias Biológicas y de Salud and the Departamento de Ciencias de la Salud.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We are grateful to the University of Sonora for the support provided for the development of this review.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Erb, M.; Kliebenstein, D.J. Plant Secondary Metabolites as Defenses, Regulators, and Primary Metabolites: The Blurred Functional Trichotomy. Plant Physiol 2020, 184, 39–52. [Google Scholar] [CrossRef] [PubMed]
  2. Li, Y.; Kong, D.; Fu, Y.; Sussman, M.R.; Wu, H. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiol Biochem 2020, 148, 80–89. [Google Scholar] [PubMed]
  3. Miransari, M.; Mahdavi, S.; Smith, D. The biological approaches of altering the growth and biochemical properties of medicinal plants under salinity stress. Applied Microbiol Biotechnol 2021, 105, 7201–7213. [Google Scholar]
  4. Chen, Y.; Garcia De Lomana, M.; Friedrich, N.O.; Kirchmair, J. Characterization of the Chemical Space of Known and Readily Obtainable Natural Products. J Chem Inf Model 2018, 58, 1518–1532. [Google Scholar] [PubMed]
  5. Schenone, M.; Dančík, V.; Wagner, B.K.; Clemons, P.A. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 2013, 9, 232–240. [Google Scholar]
  6. Veeresham, C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res 2012, 3, 200–201. [Google Scholar] [PubMed]
  7. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 2021, 20, 200–216. [Google Scholar] [PubMed]
  8. Wang, N.; Tan, H.Y.; Li, L.; Yuen, M.F.; Feng, Y. Berberine and Coptidis Rhizoma as potential anticancer agents: recent updates and future perspectives. J Ethnopharmacol 2015, 176, 35–48. [Google Scholar]
  9. Luo, H. ; Vong, C, T. ; Chen, H.; Gao, Y.; Liu, P.; Qiu, L.; Zhao, M.; Liu, Q.; Cheng, Z.; Zou, J.; Yao, P.; Gao, C.; Wei, J.; Ung, C.O.L.; Wang, S.; Zhong, Z.; Wang, Y. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med 2019, 6, 14–48. [Google Scholar]
  10. Aniszewski, T. Alkaloids: Chemistry, Biology, Ecology, and Applications, 2nd ed, Elsevier, USA, 2012, 1-475.
  11. Buckingham, J.; Baggaley, K.H.; Roberts, A.D.; Szabo, L.F. Dictionary of Alkaloids with CD-ROM, 2nd ed, USA, Boca Raton, CRC Press, 2010.
  12. Boysen, R.I.; Hearn, M.T.W. Comprehensive Natural Products II. Comprehensive Natural Products II, 2nd ed, Elsevier Science, 2010.
  13. Kukula-Koch, W.A.; Widelski, J. Pharmacognosy Fundamentals, Applications and Strategies, Boston, Academic Press, 2017.
  14. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach: Third Edition. Medicinal Natural Products: A Biosynthetic Approach, 1st ed, John Wiley and Sons, 2009.
  15. McGraw-Hill concise encyclopedia of chemistry. Choice Reviews Online. 1st ed, McGraw Hill, 2005.
  16. Qian, S.; Golubnitschaja, O.; Zhan, X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles, EPMA J 2019, 10, 365-381.
  17. Almeida, M. C; Resende, D.I.S.P.; da Costa, P.M.; Pinto, M.M.M.; Sousa, E. Tryptophan Derived Natural Marine Alkaloids and Synthetic Derivatives as Promising Antimicrobial Agents. Eur J Med Chem 2021, 209. [Google Scholar]
  18. Özçelik, B.; Kartal, M.; Orhan, I. Cytotoxicity, Antiviral and Antimicrobial Activities of Alkaloids, Flavonoids, and Phenolic Acids. Pharm Biol 2011, 49, 396–402. [Google Scholar] [CrossRef]
  19. Warowicka, A.; Nawrot, R.; Goździcka-Józefiak, A. Antiviral Activity of Berberine. Arch Virol 2020, 165, 1935–1945. [Google Scholar] [CrossRef]
  20. Pang, B.; Zhao, L.H.; Zhou, Q.; Zhao, T.Y.; Wang, H.; Gu, C.J.; Tong, X.L. Application of berberine on treating type 2 diabetes mellitus. Int J Endocrinol 2015, 2015, 905749. [Google Scholar] [CrossRef]
  21. Nugraha, A.S.; Damayanti, Y.D.; Wangchuk, P.; Keller, P.A. Anti-Infective and Anti-Cancer Properties of the Annona Species: Their Ethnomedicinal Uses, Alkaloid Diversity, and Pharmacological Activities. Molecules 2019, 24, 4419. [Google Scholar] [CrossRef]
  22. Shishido, T.K.; Popin, R.V.; Jokela, J.; Wahlsten, M.; Fiore, M.F; Fewer, D.P.; Herfindal, L.; Sivonen, K. Dereplication of Natural Products with Antimicrobial and Anticancer Activity from Brazilian Cyanobacteria. Toxins 2019, 12, 12. [Google Scholar] [CrossRef] [PubMed]
  23. Cushnie, T.P.T.; Cushnie, B.; Lamb, A.J. Alkaloids: An overview of their antibacterial, antibiotic-enhancing, and antivirulence activities. Int Journal of Antimicrob Agents 2014, 44, 377–386. [Google Scholar] [CrossRef] [PubMed]
  24. Azevedo, B.C.; Roxo, M.; Borges, M.C.; Peixoto, H.; Crevelin, E.J.; Bertoni, B.W.; Contini, S.H.T; Lopes, A.A.; Franca, S.C.; Pereira, A.M.S.; Wink, M. Antioxidant Activity of an Aqueous Leaf Extract from Uncaria Tomentosa and Its Major Alkaloids Mitraphylline and Isomitraphylline in Caenorhabditis Elegans. Molecules 2019, 24, 3299. [Google Scholar] [CrossRef] [PubMed]
  25. Martinez-Peinado, N.; Cortes-Serra, N.; Torras-Claveria, L.; Pinazo, M.J.; Gascon, J.; Bastida, J.; Alonso-Padilla, J. Amaryllidaceae Alkaloids with Anti-Trypanosoma Cruzi Activity. Parasit Vectors 2020, 13, 299. [Google Scholar] [CrossRef]
  26. LI, J.; Larregieu, C.A.; Benet, L.Z. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS). Chin J Nat Med 2016, 14, 888–897. [Google Scholar] [CrossRef]
  27. Tiwari, R.; Latheef, S.K.; Ahmed, I.; Lqbal, H.M.N.; Bule, M.H. ; Dhama K, Samad, H. A.; Karthik, K.; Alagawany, M.; Abd El-Hack, M.E.; Yatoo, M.L.; Farag, M.R. Herbal immunomodulators, a remedial panacea for the designing and developing effective drugs and medicines: Current scenario and prospects. Curr Drug Metab 2018, 19, 264–301. [Google Scholar]
  28. Yatoo, M.; Gopalakrishnan, A.; Saxena, A.; Parray, O.R.; Tufani, N.A.; Chakraborty, S.; Ruchi, T.; Dhana, K.; Lqbal, H.M.N. Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review. Recent Pat Inflamm Allergy Drug Discov 2018, 12, 39–58. [Google Scholar] [CrossRef] [PubMed]
  29. Xu, D.; Xu, Z. Indole Alkaloids with Potential Anticancer Activity. Curr Top Med Chem 2020, 20, 1938–1949. [Google Scholar] [CrossRef]
  30. Qing, Z.X.; Huang, J.L; Yang, X.Y.; Liu, J.H.; Cao, H.L. Xiang, F. ; Cheng, P.; Zeng, J. G. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship. Curr Med Chem 2018, 25, 5088–5114. [Google Scholar] [PubMed]
  31. Akhtar, J.; Khan, A.A.; Ali, Z.; Haider, R.; Shahar, Y. M. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities. Eur J Med Chem 2017, 5, 143–189. [Google Scholar] [CrossRef] [PubMed]
  32. Garuti, L.; Roberti, M.; Pizzirani, D. Nitrogen-Containing Heterocyclic Quinones: A Class of Potential Selective Antitumor Agents. Mini Rev Med Chem 2007, 7, 481–489. [Google Scholar] [CrossRef] [PubMed]
  33. Qin, H.L.; Zhang, Z.W.; Lekkala, R.; Alsulami, H.; Rakesh, K.P. Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review. Eur J Med Chem 2020, 1. [Google Scholar] [CrossRef] [PubMed]
  34. Křížová, L.; Dadáková, K.; Kašparovská, J.; Kašparovský, T. Isoflavones. Molecules 2019, 24, 1076). [Google Scholar] [CrossRef]
  35. Al-Warhi, T.; Sabt, A.; Elkaeed, E.B.; Eldehna, W.M. Recent advancements of coumarin-based anticancer agents: An up-to-date review. Bioorg Chem 2020, 103, 104163. [Google Scholar] [CrossRef]
  36. Mao, Y.; Soni, K.; Sangani, C.; Yao, Y. An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents. Curr Top Med Chem 2020, 20, 2599–2633. [Google Scholar] [CrossRef] [PubMed]
  37. Kumari, A.; Singh, RK. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. Bioorg Chem 2019, 89, 103021. [Google Scholar] [CrossRef]
  38. Kramer, C. S. Privileged Scaffolds in Medicinal Chemistry. The Royal Society of Chemistry 2015, 468. [Google Scholar]
  39. Newman, D.J; Cragg, G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod 2020, 83, 770–803. [Google Scholar] [CrossRef]
  40. Ritchie, T.J.; Macdonald, S.J.F. Physicochemical descriptors of aromatic character and their use in drug discovery. J Med Chem 2014, 57, 7206–7215. [Google Scholar] [CrossRef]
  41. Danishuddin, Khan, A. U. Descriptors and their selection methods in QSAR analysis: paradigm for drug design. Drug Discov Today, 2016, 21, 1291–1302.
  42. Gupta, A.; Kumar, V.; Aparoy, P. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study. Curr Top Med Chem 2018, 18, 1075–1090. [Google Scholar] [CrossRef]
  43. Lin, X.; Li, X.; Lin, X. A review on applications of computational methods in drug screening and design. Molecules 2020, 25, 1375. [Google Scholar] [CrossRef]
  44. Carvalho, A.L.; Trincão, J.; Romão, M.J. X-ray crystallography in drug discovery. Methods in Mol Biol 2009, 572, 31–56. [Google Scholar]
  45. Sugiki, T.; Furuita, K.; Fujiwara, T.; Kojima, C. Current NMR techniques for structure-based drug discovery. Molecules 2018, 23, 148. [Google Scholar] [CrossRef]
  46. Jacobson, K.A.; Costanzi, S. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Mol Pharmacol 2012, 82, 361–371. [Google Scholar] [CrossRef]
  47. Kist, R.; Timmers, L.F.S.M.; Caceres, R.A. Searching for potential mTOR inhibitors: Ligand-based drug design, docking and molecular dynamics studies of rapamycin binding site. J Mol Graph Model 2018, 80, 251–263. [Google Scholar] [CrossRef]
  48. Myatt, G.; Bower, D.; Cross, K.; Hasselgren, C.; Miller, S.; Quigley, D. In silico toxicology protocols and software platforms. Toxicol Lett 2017, 280, S286. [Google Scholar] [CrossRef]
  49. Ma, W.; Zhang, Y.; Yu, M.; Wang, B.; Xu, S.; Zhang, J.; Li, X.; Ye, X. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects. Int Immunopharmacol 2020, K, 106787. [Google Scholar] [CrossRef]
  50. Schett, G.; Neurath, M.F. Resolution of chronic inflammatory disease: universal and tissue-specific concepts. Nat Commun 2018, 9, 3261. [Google Scholar] [CrossRef]
  51. Leyva, M.A.P.; Robles, R.E.Z.; Razo, R.S.H. , Berber, L. P.Á.; Lara, K.O.; Ruiz, E.B.; Galvez, J.C.R. Berberine as Source of Antiproliferative Hybrid Compounds: In Vitro Antiproliferative Activity and Quantitative Structure-activity Relationship. Anticancer Agents Med Chem 2019, 19, 1820–1834. [Google Scholar]
  52. Dey, P.; Kundu, A.; Kumar, A.; Gupta, M.; Lee, B.M.; Bhakta, T.; Dash, S.; Kim, H.S. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). Recent Advances in Natural Products Analysis 2020, 505–67. [Google Scholar]
  53. Kadayat, T.M.; Banskota, S.; Bist, G.; Gurung, P.; Magar, T.B.T.; Shrestha, A.; Kim, J. A.; Lee, E.S. Synthesis and biological evaluation of pyridine-linked indanone derivatives: Potential agents for inflammatory bowel disease. Bioorg Med Chem Lett 2018, 28, 2436–2441. [Google Scholar] [CrossRef]
  54. Wang, J.; Liu, H. The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration. Front Cell and Dev Biol, 2022, 10, 843671. [Google Scholar] [CrossRef]
  55. Kumar, R.; Awasthi, M.; Sharma, A.; Padwad, Y.; Sharma, R. Berberine induces dose-dependent quiescence and apoptosis in A549 cancer cells by modulating cell cyclins and inflammation independent of mTOR pathway. Life Sci 2020, 244. [Google Scholar] [CrossRef]
  56. Chang, W. Non-coding RNAs, and Berberine: A new mechanism of its anti-diabetic activities. Eur Journal of Pharmacol 2017, 795, 8–12. [Google Scholar] [CrossRef]
  57. Li, C.L.; Tan, L.H.; Wang, Y.F.; Luo, C.D.; Chen, H.B.; Lu, Q.; Li, Y.C.; Yang, X.B.; Chen, J.N.; Liu, Y.H.; Xie, J.H.; Su, Z.R. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo. Phytomedicine 2019, 52, 272–283. [Google Scholar] [CrossRef]
  58. Wang, Y.X.; Pang, W.Q.; Zeng, Q.X.; Deng, Z.S.; Fan, T.Y.; Jiang, J.D.; Deng, H.B.; Song, D.Q. Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1. Eur J Med Chem 2018, 143, 1858–1868. [Google Scholar] [CrossRef] [PubMed]
  59. Liu, J.; Li, H.; Chen, K.X.; Zuo, J.P.; Guo, Y.W.; Tang, W.; Li, X.W. Design and Synthesis of Marine Phidianidine Derivatives as Potential Immunosuppressive Agents. J Med Chem 2018, 61, 11298–11308. [Google Scholar] [CrossRef] [PubMed]
  60. Costa de Oliveira, R.; Soares, G.; Kostyuk, A.; Coutinho, G.B.; Dhyani, A.; Shvydenko, T.; Shvydenko, K.; Grafov, A. Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine. Molecules 2020, 25, 2130. [Google Scholar] [CrossRef] [PubMed]
  61. Márquez, E.; Mora, J.R.; Flores, V.; Insuasty, D.; Calle, L. Modeling the Antileukemia Activity of Ellipticine-Related Compounds: QSAR and Molecular Docking Study. Molecules 2020, 25, 24. [Google Scholar] [CrossRef] [PubMed]
  62. Dai, P.; Chen, S.; Wang, M.; Ma, H.; Liu, F.; Lin, C.; Zhu, C. β-Carboline alkaloids from Picrasma quassioides and their 3D-QSAR study on anti-inflammation in LPS-induced RAW 264.7 cells. Fitoterapia 2023, 166, 105437. [Google Scholar] [CrossRef]
  63. Li, X.; Li, N.; Sui, Z.; Bi, K.; Li, Z. An investigation on the quantitative structure-activity relationships of the anti-inflammatory activity of diterpenoid alkaloids. Molecules 2017, 22, 363. [Google Scholar] [CrossRef]
Preprints 108502 g001
Figure 1. Heterocyclic structures are most used in new drug development. Cyclic structures, such as chalcone, isoflavone, and coumarin, are present in several alkaloid groups with pharmacological properties.
Figure 1. Heterocyclic structures are most used in new drug development. Cyclic structures, such as chalcone, isoflavone, and coumarin, are present in several alkaloid groups with pharmacological properties.
Preprints 108502 g001
Table 1. Classification and Biological activities of Alkaloids with QSAR and Immunomodulatory effects.
Table 1. Classification and Biological activities of Alkaloids with QSAR and Immunomodulatory effects.
Classification Derivates Compound Activity References
True alkaloids Aspartate Pyridine-linked hydroxylated Indanones Anti-Inflammatory Bowel Disease 53
Phenylalanine and Tyrosine Berberine Anti-proliferative, anti-bacterial 51, 58
Protoalkaloids Tryptophan Indole Phidianidines Cytotoxic, Neuroprotective dopamine transporter inhibitory and protein tyrosine phosphatase-1B inhibitory 59
Ellipticine Immunomodulation 60, 61
β-carboline 62
Pseudoalkaloids Diterpenoid songorine, delsolin, and fulzulin NO Inhibition 63
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated